Vaxcyte Inc (PCVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -402,266 | -221,465 | -128,801 | -60,462 | -223,485 |
| Depreciation Amortization | -24,604 | -25,183 | -13,091 | -3,648 | 8,506 |
| Accounts payable and accrued liabilities | 11,225 | 4,746 | 4,052 | 1,789 | 2,896 |
| Other Working Capital | 81,320 | 43,256 | 9,268 | 6,772 | 12,737 |
| Other Operating Activity | 37,535 | 30,666 | 18,140 | 7,859 | 28,749 |
| Operating Cash Flow | $-296,790 | $-167,980 | $-110,432 | $-47,690 | $-170,597 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,329,896 | -1,126,286 | -916,613 | -483,779 | -102,745 |
| PPE Investments | -16,062 | -10,808 | -3,469 | -5,609 | -5,841 |
| Sale Of Investment | 624,462 | 377,709 | 138,417 | 41,287 | 183,171 |
| Other Investing Activity | -51,815 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-773,311 | $-759,385 | $-781,665 | $-448,101 | $74,585 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 636,043 | 640,624 | 547,682 | 502 | 856,480 |
| Other Financing Activity | 3,770 | -3,546 | 40,846 | 41,060 | 5,067 |
| Financing Cash Flow | $639,813 | $637,078 | $588,528 | $41,562 | $861,547 |
| Exchange Rate Effect | -6,686 | 996 | -55 | 23 | 137 |
| Beginning Cash Position | 835,528 | 835,528 | 835,528 | 835,528 | 69,856 |
| End Cash Position | 398,554 | 546,237 | 531,904 | 381,322 | 835,528 |
| Net Cash Flow | $-436,974 | $-289,291 | $-303,624 | $-454,206 | $765,672 |
| Free Cash Flow | |||||
| Operating Cash Flow | -296,790 | -167,980 | -110,432 | -47,690 | -170,597 |
| Capital Expenditure | -16,062 | -10,808 | -3,469 | -5,609 | -5,841 |
| Free Cash Flow | -312,852 | -178,788 | -113,901 | -53,299 | -176,438 |